Anticorps Recombinant de lapin anti-CD62P

CD62P Recombinant Antibody for FC

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain

Applications

FC

Conjugaison

FITC Plus Fluorescent Dye

CloneNo.

AK4

N° de cat : FITC-65587

Synonymes

P-selectin, GMRP, GMP-140, GMP140, GMP 140



Applications testées

Résultats positifs en cytométrieThrombin treated human peripheral blood platelets,

Dilution recommandée

ApplicationDilution
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood.
Sample-dependent, check data in validation data gallery

Informations sur le produit

FITC-65587 cible CD62P dans les applications de FC et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Mouse / IgG2a
Clonalité Recombinant
Type Anticorps
Immunogène Plaquettes humaines
Nom complet selectin P (granule membrane protein 140kDa, antigen CD62)
Masse moléculaire calculée 830 aa, 91 kDa
Numéro d’acquisition GenBankBC028067
Symbole du gène CD62P
Identification du gène (NCBI) 6403
Conjugaison FITC Plus Fluorescent Dye
Excitation/Emission maxima wavelengths495 nm / 524 nm
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.09% sodium azide
Conditions de stockageStore at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

Informations générales

P-selectin, also known as GMP140 or CD62P, is a transmembrane glycoprotein that mediates the interaction of activated endothelial cells or platelets with leukocytes. It is an adhesion molecule involved in the pathogenesis of inflammation, thrombosis, and oncogenesis. P-selectin is stored in the alpha-granules of platelets and Weibel-Palade bodies of endothelial cells. Upon cell activation by agonists, P-selectin is transported rapidly to the cell surface.

Protocole

Product Specific Protocols
FC protocol for FITC Plus CD62P antibody FITC-65587Download protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}